← Open Payments lookup

JESSICA MANN: Open Payments

NPI 1336793751 · BATESVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,604 in 87 payments from 24 companies in 2025. Trend: 2023 $31 · 2024 $1,018 · 2025 $1,604

Food & beverage: $1,604
CompanyPaymentsAmount
Ardelyx, Inc.13$256
Bayer Healthcare Pharmaceuticals Inc.12$209
GlaxoSmithKline, LLC.10$170
Novo Nordisk Inc9$145
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$123
Takeda Pharmaceuticals U.S.A., Inc.5$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$85
Xeris Pharmaceuticals, Inc.4$80
Janssen Pharmaceuticals, Inc4$72
AstraZeneca Pharmaceuticals LP3$65

Products named: IBSRELA, Kerendia, TRELEGY ELLIPTA, TRINTELLIX, CAPLYTA, XIFAXAN, Ozempic, SPRAVATO.

Industry payments across MS — which companies pay providers there.